Wells Fargo & Company Heron Therapeutics, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 60,602 shares of HRTX stock, worth $118,173. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,602

Previous 41,364 46.51%

Holding current value

$118,173

Previous $114,000 85.96%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.32 - $3.86 $44,632 - $74,258	19,238 Added 46.51%	60,602 $212,000
Q1 2024 May 10, 2024	BUY	$1.71 - $3.06 $6,860 - $12,276	4,012 Added 10.74%	41,364 $114,000
Q4 2023 Feb 09, 2024	BUY	$0.54 - $1.82 $3,695 - $12,454	6,843 Added 22.43%	37,352 $63,000
Q3 2023 Nov 13, 2023	SELL	$0.97 - $1.8 $21,121 - $39,195	-21,775 Reduced 41.65%	30,509 $31,000
Q2 2023 Aug 15, 2023	BUY	$1.11 - $2.88 $23,787 - $61,718	21,430 Added 69.46%	52,284 $60,000
Q1 2023 May 12, 2023	BUY	$1.51 - $3.25 $31,524 - $67,850	20,877 Added 209.25%	30,854 $46,000
Q4 2022 Feb 13, 2023	SELL	$2.25 - $4.67 $8,487 - $17,615	-3,772 Reduced 27.43%	9,977 $24,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $85,356 - $172,317	-32,089 Reduced 70.01%	13,749 $58,000
Q2 2022 Aug 12, 2022	SELL	$2.3 - $6.29 $127,072 - $347,516	-55,249 Reduced 54.65%	45,838 $128,000
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $14,005 - $30,068	-3,025 Reduced 2.91%	101,087 $579,000
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $542,557 - $818,710	-64,977 Reduced 38.43%	104,112 $951,000
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $25,790 - $38,190	2,546 Added 1.53%	169,089 $1.81 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $738,263 - $1.03 Million	55,634 Added 50.16%	166,543 $2.59 Million
Q1 2021 May 13, 2021	SELL	$14.49 - $20.72 $1.43 Million - $2.05 Million	-98,892 Reduced 47.14%	110,909 $1.8 Million
Q4 2020 Feb 09, 2021	SELL	$14.61 - $22.14 $168,365 - $255,141	-11,524 Reduced 5.21%	209,801 $4.44 Million
Q3 2020 Nov 05, 2020	SELL	$13.67 - $17.77 $624,486 - $811,786	-45,683 Reduced 17.11%	221,325 $3.28 Million
Q2 2020 Aug 13, 2020	BUY	$10.89 - $21.47 $2.14 Million - $4.21 Million	196,234 Added 277.27%	267,008 $3.93 Million
Q1 2020 May 14, 2020	BUY	$10.23 - $24.56 $724,018 - $1.74 Million	70,774 New	70,774 $831,000

Others Institutions Holding HRTX

# of Institutions

198

Shares Held

129M

Call Options Held

94.7K

Put Options Held

148K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $232M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Heron Therapeutics, Inc. Transaction History